| Bioactivity | Tetomilast (OPC-6535) is a PDE4 inhibitor with potential for the treatment of inflammatory bowel disease (IBD) and chronic obstructive pulmonary disease (COPD). |
| Name | Tetomilast |
| CAS | 145739-56-6 |
| Formula | C19H18N2O4S |
| Molar Mass | 370.42 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Ichikawa H, Okamoto S, Kamada N, et al. Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL-10-deficient mice. Inflamm Bowel Dis. 2008;14(11):1483-1490. |
Tetomilast
CAS: 145739-56-6 F: C19H18N2O4S W: 370.42
Tetomilast (OPC-6535) is a PDE4 inhibitor with potential for the treatment of inflammatory bowel disease (IBD) and chron
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.